Science and Discovery

Targeted Therapy

1 article

Medical researcher examining a glowing molecular model of Daraxonrasib, with hopeful patients in the background, symbolizing a breakthrough in pancreatic cancer treatment.
Health & Medicine

Daraxonrasib Doubles Survival in Pancreatic Cancer Treatment Trials

In a recent clinical trial, patients with advanced pancreatic cancer receiving Daraxonrasib lived more than twice as long as those on standard chemotherapy.

David Grossman·June 19, 2026